These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3702795)

  • 1. Accidental coadministration of intravenous aminophylline and theophylline by mouth: a hazardous practice.
    Frewin DB; Cooper DJ
    Med J Aust; 1986 Apr; 144(9):481-2. PubMed ID: 3702795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose conversion from aminophylline to theophylline in preterm infants.
    Reese J; Prentice G; Yu VY
    Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F51-2. PubMed ID: 8092873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission.
    Wiggins J; Arbab OA; Stableforth DE; Ayres JG
    Thorax; 1986 Oct; 41(10):759-65. PubMed ID: 3538477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of theophylline clearance in determining maintenance intravenous aminophylline therapy.
    Grambau GR; Johnson CE; Conlon PF; Weg JG
    J Clin Pharmacol; 1985; 25(5):381-3. PubMed ID: 4031115
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.
    Silins RA; Butcher MA; Marlin GE
    Br J Clin Pharmacol; 1984 Oct; 18(4):645-7. PubMed ID: 6487509
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of theophylline and aminophylline in man.
    Aslaksen A; Bakke OM; Vigander T
    Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.
    Weinberger MW; Matthay RA; Ginchansky EJ; Chidsey CA; Petty TL
    JAMA; 1976 May; 235(19):2110-3. PubMed ID: 946537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous aminophylline.
    Van Dellen RG
    Chest; 1979 Jul; 76(1):2-3. PubMed ID: 446166
    [No Abstract]   [Full Text] [Related]  

  • 13. Doses of aminophylline given intravenously in casualty department and resulting serum theophylline concentrations.
    Munro CS; Prowse K
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):354-5. PubMed ID: 6432095
    [No Abstract]   [Full Text] [Related]  

  • 14. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of theophylline clearance to design an oral aminophylline regimen.
    Simmons SM; Camp RB; Mungall DR; Bailey WC
    Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
    [No Abstract]   [Full Text] [Related]  

  • 17. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics in drug therapy II: Applications of clinical pharmacokinetics in the assessment of theophylline therapy.
    Floyd RA; Cohen JL
    Am J Hosp Pharm; 1977 Apr; 34(4):402-7. PubMed ID: 871124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.